Tricyclic Antidepressant (TCA) — OCD Specialist
Pregnancy: Avoid — neonatal anticholinergic effects and withdrawal syndrome. Sertraline preferred.
Clomipramine
Brand names: Anafranil
Adult dose
Dose: OCD: 25mg OD initially; increase over 2 weeks to 100–150mg OD; maximum 250mg OD. Depression: 10mg OD initially; increase to 30–150mg daily (divided or single dose at night); maximum 250mg daily. Phobic and anxiety states: 75–150mg daily.
Route: Oral
Frequency: Once daily at night or divided doses
Max: 250mg OD
Most serotonergic of all TCAs — gold standard pharmacotherapy for OCD, with the strongest evidence base. NICE recommends clomipramine as second-line (after SSRI failure) for OCD. Higher seizure risk than other TCAs at doses above 250mg. Therapeutic plasma levels 230–450 nanograms/mL (clomipramine + N-desmethylclomipramine).
Paediatric dose
Route: Oral
Frequency: Once daily at night
Max: 200mg OD or 3mg/kg (whichever is lower)
BNFc: OCD (10–17 years): 25mg OD initially; increase over 2 weeks to 3mg/kg OD (max 200mg OD). Seek specialist child and adolescent psychiatry opinion.
Dose adjustments
Renal
Use with caution — risk of accumulation in severe impairment.
Hepatic
Avoid in severe hepatic impairment.
Clinical pearls
- NICE CG31: clomipramine is second-line for OCD after one or two SSRI trials fail — strongest evidence of any TCA for OCD due to its serotonin selectivity
- OCD doses are typically higher than antidepressant doses (up to 250mg) — seizure risk increases significantly above this dose
- Overdose: as per other TCAs — IV sodium bicarbonate for QRS widening (cardiac toxicity antidote)
- Serotonin syndrome risk: highest of all TCAs — avoid combining with tramadol, lithium, other serotonergic drugs
Contraindications
- Recent MI
- Arrhythmias, heart block
- Mania (risk of switch)
- Closed-angle glaucoma
- MAOIs within 14 days
- Hypersensitivity to clomipramine
Side effects
- Sedation
- Dry mouth, constipation (anticholinergic)
- QTc prolongation
- Seizures (dose-related, >250mg)
- Sexual dysfunction (very common)
- Weight gain
- Orthostatic hypotension
Interactions
- MAOIs — contraindicated
- SSRIs (especially fluvoxamine) — significantly increase clomipramine levels; avoid combination
- Antiarrhythmics — additive cardiac toxicity
- Tramadol — serotonin syndrome + seizure risk
Monitoring
- ECG (QTc)
- Plasma levels (clomipramine + N-desmethylclomipramine)
- Seizure history (dose above 200mg)
- OCD symptom rating (Y-BOCS score)
Reference: BNFc; BNF 90; NICE CG31 (OCD). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF